These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6358282)

  • 21. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
    Mahrle G; Schulze HJ; Färber L; Weidinger G; Steigleder GK
    J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclosporin versus etretinate: Italian multicenter comparative trial in severe plaque-form psoriasis. Italian Multicenter Study Group on Cyclosporin in Psoriasis.
    Dermatology; 1993; 187 Suppl 1():8-18. PubMed ID: 8369579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etretinate therapy causes increases in lipid levels in patients with psoriasis.
    Ellis CN; Swanson NA; Grekin RC; Goldstein NG; Bassett DR; Anderson TF; Voorhees JJ
    Arch Dermatol; 1982 Aug; 118(8):559-62. PubMed ID: 7103524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etretinate therapy for generalized pustular psoriasis in children.
    Shelnitz LS; Esterly NB; Honig PJ
    Arch Dermatol; 1987 Feb; 123(2):230-3. PubMed ID: 3545086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generalized pustular psoriasis in a child.
    van de Kerkhof PC
    Dermatologica; 1985; 170(5):244-8. PubMed ID: 4007219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acitretin in the treatment of severe psoriasis: a randomized double-blind study comparing acitretin and etretinate.
    Meffert H; Sönnichsen N
    Acta Derm Venereol Suppl (Stockh); 1989; 146():176-7. PubMed ID: 2532846
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of systemic etretinate treatment on natural cytotoxicity, immune angiogenesis and neutrophil adherence in patients with various forms of psoriasis.
    Majewski S; Wolska H; Jabłońska S; Wasik M
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):459-64. PubMed ID: 2484150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of psoriatic arthropathy with etretinate: a two-year follow-up.
    Chieregato GC; Leoni A
    Acta Derm Venereol; 1986; 66(4):321-4. PubMed ID: 2430403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of psoriasis with etretin: a preliminary report.
    Madhok R; Muller SA; Dicken CH
    Mayo Clin Proc; 1987 Dec; 62(12):1084-9. PubMed ID: 2960861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of etretinate and fish oil in psoriasis therapy. Inhibition of hypertriglyceridemia resulting from retinoid therapy after fish oil supplementation.
    Frati C; Bevilacqua L; Apostolico V
    Acta Derm Venereol Suppl (Stockh); 1994; 186():151-3. PubMed ID: 8073820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic treatment of psoriasis with an oral retinoic acid derivative (Ro 10-9359).
    Lassus A
    Br J Dermatol; 1980 Feb; 102(2):195-202. PubMed ID: 6992833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral retinoid for psoriasis. A report of a double blind study.
    Pettit JH
    Acta Derm Venereol Suppl (Stockh); 1979; 59(85):133-6. PubMed ID: 393035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Etretinate: pro and con. Risk-benefit analysis of systemic retinoid therapy in psoriasis and recent developments: free aromatic acid, arotinoids].
    Gollnick H; Orfanos CE
    Hautarzt; 1985 Jan; 36(1):2-9. PubMed ID: 3156105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The profile and outcome of pustular psoriasis in Singapore: a report of 28 cases.
    Tay YK; Tham SN
    Int J Dermatol; 1997 Apr; 36(4):266-71. PubMed ID: 9169323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulfasalazine improves psoriasis. A double-blind analysis.
    Gupta AK; Ellis CN; Siegel MT; Duell EA; Griffiths CE; Hamilton TA; Nickoloff BJ; Voorhees JJ
    Arch Dermatol; 1990 Apr; 126(4):487-93. PubMed ID: 1690970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double blind clinical trial of Tigason (Ro 10-9359) versus placebo in psoriasis.
    Jakubowicz K; Gruca S; Nowakowski H
    Acta Univ Carol Med (Praha); 1986; 32(3-4):229-32. PubMed ID: 3324721
    [No Abstract]   [Full Text] [Related]  

  • 37. PUVA, etretinate, and PUVA-etretinate therapy for pustulosis palmoplantaris. A placebo-controlled comparative trial.
    Rosén K; Mobacken H; Swanbeck G
    Arch Dermatol; 1987 Jul; 123(7):885-9. PubMed ID: 3300565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical trial of the efficacy and safety of oral etretinate with calcipotriol cream compared with etretinate alone in moderate-severe psoriasis.
    Giannetti A; Coppini M; Bertazzoni MG; Califano A; Altieri E; Pazzaglia A; Lega M; Lombardo M; Pelfini C; Veller Fornasa C; Rabbiosi G; Cespa M
    J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):91-5. PubMed ID: 10568486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of generalized pustular psoriasis with etretinate (Ro 10-9359) and methotrexate.
    Rosenbaum MM; Roenigk HH
    J Am Acad Dermatol; 1984 Feb; 10(2 Pt 2):357-61. PubMed ID: 6707259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficiency of acitretin in combination with UV-B in the treatment of severe psoriasis.
    Ruzicka T; Sommerburg C; Braun-Falco O; Köster W; Lengen W; Lensing W; Letzel H; Meigel WN; Paul E; Przybilla B
    Arch Dermatol; 1990 Apr; 126(4):482-6. PubMed ID: 2138875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.